Funder: American Cancer Society
Due Dates (Anticipated): June 2026 (Full application, June cycle) | December 2026 (Full application, December cycle)
Funding Amounts: Stage I: Up to $135,000/year direct costs + 10% indirect (max $297,000 total, 2 years); Stage II: Up to $545,000 direct + 10% indirect (max 18 months)
Summary: Supports independent investigators in translating innovative cancer research from laboratory discovery to human clinical testing.
Key Information: This is a forecasted opportunity; dates and details subject to change—refer to program page for updates.